{
    "2019-11-01": [
        [
            {
                "time": "2018-11-01",
                "original_text": "复星医药控股子公司Grand Pharma拟在印度证交所和孟买证交所上市 合景泰富10月预售额升123.6%至101.28亿元",
                "features": {
                    "keywords": [
                        "复星医药",
                        "Grand Pharma",
                        "印度上市",
                        "合景泰富",
                        "预售额"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "房地产"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "下周333亿市值限售股解禁，环比减少36.41% 解禁",
                "features": {
                    "keywords": [
                        "限售股",
                        "解禁",
                        "市值"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "复星医药：第八届董事会第八次会议（临时会议）决议公告",
                "features": {
                    "keywords": [
                        "复星医药",
                        "董事会",
                        "决议公告"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "A股头条之上市公司（11.1）",
                "features": {
                    "keywords": [
                        "A股",
                        "上市公司"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "复星医药一控股子公司拟境外上市",
                "features": {
                    "keywords": [
                        "复星医药",
                        "控股子公司",
                        "境外上市"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "复星医药(02196.HK)子公司禅城医院向深圳复星健康注资1040.8万元持股51%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "禅城医院",
                        "注资",
                        "深圳复星健康"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "实锤：4+7中选药采购量扩增6倍，9000药品将遭临床替代",
                "features": {
                    "keywords": [
                        "4+7",
                        "药品采购",
                        "临床替代"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "[复星医药]19Q3季报点评：扣非增速较高，创新转型稳步推进",
                "features": {
                    "keywords": [
                        "复星医药",
                        "季报",
                        "扣非增速",
                        "创新转型"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "复星医药(02196-HK)子公司禪城医院开拓互联网的新医疗服务",
                "features": {
                    "keywords": [
                        "复星医药",
                        "禪城医院",
                        "互联网医疗"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "互联网"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "[异动股]青蒿素板块拉升，浙江医药(600216-CN)涨停",
                "features": {
                    "keywords": [
                        "青蒿素",
                        "浙江医药",
                        "涨停"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "恒指低开0.37% 地产代理板块领跌",
                "features": {
                    "keywords": [
                        "恒指",
                        "低开",
                        "地产代理",
                        "领跌"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "房地产",
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}